SINOPOL® him is a health supplement assisting with the production of healthy sperm and supporting fertility by reducing oxidative stress, improving sperm parameters, rebalancing testosterone and decreasing insulin resistance. 1-4 SINOPOL® him is a health supplement which contains the powerful antioxidant alpha-lipoic acid and myo-inositol, a vitamin like substance, 6 both shown to assist with the production of healthy sperm and support fertility by reducing oxidative stress, while also re-balancing testosterone and decreasing insulin resistance, yet another factor that can negatively affect sperm health. 1,2,3,7 SINOPOL® him also contains coenzyme Q10, selenium, zinc and vitamins B2, B6 and B12, all active ingredients designed to help restore normal male fertility and reproductive health.
1. Sinopol® him approved package insert, October 2019. 2. Canepa P, Dal Lago A, De Leo C, et al. Combined treatment with myo-inositol, alpha-lipoic acid, folic acid and vitamins significantly improves sperm parameters of sub-fertile men: a multi-centric study. Eur Rev Med Pharmacol Sci 2018; 22:7078-7085. 3. Agarwal A, Virk G, Ong C, et al. Effect of Oxidative Stress on Male Reproduction. World J Mens Health 2014;32(1):1-17. 7. Konrad D, Somwar R, Sweeney G, et al. The Antihyperglycemic Drug a-Lipoic Acid Stimulates Glucose Uptake via Both GLUT4 Translocation and GLUT4 Activation. Potential Role of p38 Mitogen-Activated Protein Kinase in GLUT4 Activation. Diabetes 2001;50:1464–1471.
Proprietary name (and dosage form): SINOPOL® him Granules. Composition: Each sachet contains: Myo-inositol 500 mg, Alpha Lipoic Acid 400 mg, Coenzyme Q1O 100 mg, Zinc 7,5 mg, Vitamin B2 1,4 mg, Vitamin B6 1,4 mg, Selenium 41,5 μg and Vitamin B12 2,5 μg. Complementary Medicine: Health Supplement. D34.12 Multiple Substance formulation. This unregistered medicine has not been evaluated by SAHPRA for its quality, safety or intended use. Studies as part of the references were not conducted on Sinopol® Him sachets; efficacy is proven on active ingredients. For more information, contact iNova Pharmaceuticals.